China's healthcare sꦆystem is hospital-centric, with publiℱc hospitals delivering approximately 90% of the inpatient and outpatient care consumed in the country in both hospitals and basic medical institutions. Nearly 40% of hospitals’ revenue is ...

The pharmaceutical sector in the Czech Republic generated a gross value added (GVA) of CZK 18.9bn in 2016, up by 8.2% y/y in real terms. It accounted for 0.44% of the total GVA in the economy in 2016. The sector employed 9,438 workers. T🉐otal ...

Brazil is the eighth-largest pharmaceu𓃲tical market in the world. In 2016, the retail drug market, based on ex-factory prices, rose by 15.5% y/y to BRL 87.2bn, supported by upward price dynamics and steady demand for innovative patented drugs. In ...

China's healthcare system is hospi🦋tal-cen🤪tric, with public hospitals delivering approximately 90% of the inpatient and outpatient care consumed in the country in both hospitals and basic medical institutions. Nearly 40% of hospitals’ revenue is ...

India’s 1.3-bn population has given rise to a sizeable healthcare sector and one of the large𓄧st pharmaceutical markets in Asia. Both the healthcare and drug markets are plagued by uneven geographical spread, low levels of public expenditure and ...

China's healthcare system i🐽s hospital-centric, with public hospitals delivering approximately 90% of the inpatient and outpatient care consumed in the country in both hospitals and basic medical institutions. Nearly 40% of hospitals’ revenue is ...

The Philippines healthcare and pharmaceuticals sect♍or has grown gradually in past years due to the 🐻country’s population and economic growth. Recently, sector growth has accelerated due to policy measures to increase the healthcare budget which ...

Indonesia's healthcare and pharmaceuticals industry is one of 🏅the least developed in ASEAN and Indonesia has low scores on most metrics – including number of hospitals and beds per 10,000 population and healthcare expenditure per capita. These ...

The Malaysian healthcare and pharmaceuticꦦals sector has꧒ been growing strongly as a result of factors including one of the highest population growth rates in the ASEAN region, increasing affluence, and growing access to healthcare funding. In ...

Thailand is the second-largest pharmaceutical market in South East Asia, with sales of THB 152.9bn in 2015. The pharmaceutical industry specialises in generic drug production and this is🧸 the largest segment on the ma🍸rket. Spending on health is ...